We are developping a clinical trial that evaluates the efficacy and safety of an oral medication that inhibits an enzyme released by a dental germ in patients with moderate Alzheimer’s disease.
The GAIN trial (code COR388-010) is a phase III clinical trial and we are carrying out in Spain, in the General University Hospital of Catalonia, with the collaboration between the services of neurology, neuropsychology, neuroradiology and odontology, coordinated by Dr. Balaguer, neurologist and director of research.
